Fiche publication


Date publication

décembre 2025

Journal

Vaccine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr THILLY Nathalie


Tous les auteurs :
Bocquier A, Cadoret S, Fall E, Bonnay S, LeDuc-Banaszuk AS, Branchereau M, Gauchet A, Bruel S, Gagneux-Brunon A, Giraudeau B, Michel M, Mueller JE, Lefèvre B, Thilly N,

Résumé

Human papillomavirus vaccine coverage (HPV VC) remains suboptimal in many countries. French authorities launched the PrevHPV research program, which included a cluster randomized controlled trial (cRCT) to evaluate the effectiveness of an 'at-school vaccination' intervention. Within this trial, we conducted a process evaluation of this intervention, specifically analyzing (i) its implementation, (ii) its mechanisms of impact, and (iii) the contextual factors influencing implementation (facilitators/barriers).

Mots clés

Acceptability, Human papillomavirus, Implementation, Mixed-method study, School-based immunization program, Vaccination

Référence

Vaccine. 2025 12 17;72:128122